Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIP-SAP trial of nandrolone-based multimodal rehabilitation after hip fracture
2017-001543-13Phase 2Terminated
- Sponsor
- Morten Tange Kristensen/Hvidovre Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hip fracture comparing Multimodal rehabilitation + Deca-Durabolin with Multimodal rehabilitation + placebo (2 arms). Primary endpoint: Change in maximal isometric knee-extension strength in the fractured limb. Started Feb 2018; status: terminated.
02
Drugs
nandrolone
03
Conditions
hip fracture
Beyond the preview
Go deeper on 2017-001543-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001543-13.